{"title":"An Overview of the Deubiquitinase USP53: A Promising Diagnostic Marker and Therapeutic Target","authors":"Guangce Xia, Yulin Guo, Jiajia Zhang, Meng Han, Xiangchao Meng, Ji Lv","doi":"10.2174/0113892037292440240518194922","DOIUrl":"https://doi.org/10.2174/0113892037292440240518194922","url":null,"abstract":"\u0000\u0000Ubiquitination and deubiquitination are important mechanisms to maintain normal physiological\u0000activities, and their disorders or imbalances can lead to various diseases. As a subgroup of\u0000deubiquitinases (DUBs), the ubiquitin-specific peptidase (USP) family is closely related to many\u0000biological processes. USP53, one of the family members, is widely expressed in human tissues and\u0000participates in a variety of life activities, such as cell apoptosis, nerve transmission, and bone remodeling.\u0000Mutations in the USP53 gene can cause cholestasis and deafness and may also be a potential\u0000cause of schizophrenia. Knockout of USP53 can alleviate neuropathic pain induced by\u0000chronic constriction injury. Loss of USP53 up-regulates RANKL expression, promotes the cytogenesis\u0000and functional activity of osteoclasts, and triggers osteodestructive diseases. USP53 plays a\u0000tumor-suppressive role in lung cancer, renal clear cell carcinoma, colorectal cancer, liver cancer,\u0000and esophageal cancer but reduces the radiosensitivity of cervical cancer and esophageal cancer to\u0000induce radioresistance. Through the in-depth combination of literature and bioinformatics, this review\u0000suggested that USP53 may be a good potential biomarker or therapeutic target for diseases.\u0000","PeriodicalId":438625,"journal":{"name":"Current Protein & Peptide Science","volume":"101 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141389133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Enzymatic Targets in the Anticancer Drug Discovery","authors":"L. Scotti, M. Scotti","doi":"10.2174/138920372501240109145132","DOIUrl":"https://doi.org/10.2174/138920372501240109145132","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":438625,"journal":{"name":"Current Protein & Peptide Science","volume":"35 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139455682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tribute to Prof. Ben M. Dunn: A Remarkable Biochemist and\u0000Editor-in-Chief of Current Protein & Peptide Science and\u0000Protein & Peptide Letters","authors":"","doi":"10.2174/138920372501240109105124","DOIUrl":"https://doi.org/10.2174/138920372501240109105124","url":null,"abstract":"","PeriodicalId":438625,"journal":{"name":"Current Protein & Peptide Science","volume":"6 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139457268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}